rs41312114

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_006044.4(HDAC6):​c.3248G>A​(p.Gly1083Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00328 in 1,208,599 control chromosomes in the GnomAD database, including 6 homozygotes. There are 1,217 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G1083S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0020 ( 0 hom., 57 hem., cov: 22)
Exomes 𝑓: 0.0034 ( 6 hom. 1160 hem. )

Consequence

HDAC6
NM_006044.4 missense

Scores

1
5
11

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 2.33

Publications

7 publications found
Variant links:
Genes affected
HDAC6 (HGNC:14064): (histone deacetylase 6) Histones play a critical role in transcriptional regulation, cell cycle progression, and developmental events. Histone acetylation/deacetylation alters chromosome structure and affects transcription factor access to DNA. The protein encoded by this gene belongs to class II of the histone deacetylase/acuc/apha family. It contains an internal duplication of two catalytic domains which appear to function independently of each other. This protein possesses histone deacetylase activity and represses transcription. [provided by RefSeq, Jul 2008]
HDAC6 Gene-Disease associations (from GenCC):
  • X-linked dominant chondrodysplasia, Chassaing-Lacombe type
    Inheritance: XL Classification: MODERATE, SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010107607).
BP6
Variant X-48823730-G-A is Benign according to our data. Variant chrX-48823730-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 445469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Hemizygotes in GnomAd4 at 57 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HDAC6NM_006044.4 linkc.3248G>A p.Gly1083Asp missense_variant Exon 26 of 29 ENST00000334136.11 NP_006035.2 Q9UBN7-1A0A024QZ26Q9NSW6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HDAC6ENST00000334136.11 linkc.3248G>A p.Gly1083Asp missense_variant Exon 26 of 29 1 NM_006044.4 ENSP00000334061.5 Q9UBN7-1

Frequencies

GnomAD3 genomes
AF:
0.00199
AC:
222
AN:
111609
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.000326
Gnomad AMI
AF:
0.00441
Gnomad AMR
AF:
0.000190
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00390
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00169
AC:
304
AN:
179820
AF XY:
0.00152
show subpopulations
Gnomad AFR exome
AF:
0.000620
Gnomad AMR exome
AF:
0.000110
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00360
Gnomad OTH exome
AF:
0.00112
GnomAD4 exome
AF:
0.00341
AC:
3744
AN:
1096941
Hom.:
6
Cov.:
30
AF XY:
0.00320
AC XY:
1160
AN XY:
362359
show subpopulations
African (AFR)
AF:
0.000493
AC:
13
AN:
26384
American (AMR)
AF:
0.0000569
AC:
2
AN:
35139
Ashkenazi Jewish (ASJ)
AF:
0.000207
AC:
4
AN:
19361
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30183
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53900
European-Finnish (FIN)
AF:
0.000124
AC:
5
AN:
40455
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4135
European-Non Finnish (NFE)
AF:
0.00433
AC:
3644
AN:
841340
Other (OTH)
AF:
0.00165
AC:
76
AN:
46044
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
135
270
406
541
676
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
150
300
450
600
750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00199
AC:
222
AN:
111658
Hom.:
0
Cov.:
22
AF XY:
0.00169
AC XY:
57
AN XY:
33822
show subpopulations
African (AFR)
AF:
0.000326
AC:
10
AN:
30721
American (AMR)
AF:
0.000190
AC:
2
AN:
10519
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2644
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3542
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2651
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6113
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
212
European-Non Finnish (NFE)
AF:
0.00390
AC:
207
AN:
53053
Other (OTH)
AF:
0.00
AC:
0
AN:
1522
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
10
19
29
38
48
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00276
Hom.:
143
Bravo
AF:
0.00179
TwinsUK
AF:
0.00243
AC:
9
ALSPAC
AF:
0.00623
AC:
18
ESP6500AA
AF:
0.000782
AC:
3
ESP6500EA
AF:
0.00342
AC:
23
ExAC
AF:
0.00187
AC:
227

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 22, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

HDAC6-related disorder Benign:1
Mar 19, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.20
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.26
T;T;T;T;T;.
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Benign
0.83
.;.;.;.;T;T
M_CAP
Pathogenic
0.66
D
MetaRNN
Benign
0.010
T;T;T;T;T;T
MetaSVM
Benign
-0.85
T
MutationAssessor
Uncertain
2.1
M;M;M;M;M;.
PhyloP100
2.3
PrimateAI
Benign
0.44
T
PROVEAN
Benign
-2.2
N;.;N;.;.;.
REVEL
Uncertain
0.36
Sift
Benign
0.15
T;.;T;.;.;.
Sift4G
Uncertain
0.029
D;.;D;.;.;.
Polyphen
1.0
D;D;D;D;D;.
Vest4
0.59
MVP
0.82
MPC
0.39
ClinPred
0.030
T
GERP RS
5.6
PromoterAI
0.030
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.33
gMVP
0.66
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41312114; hg19: chrX-48682140; API